A trial to study the effectiveness of Multi Component Behavioural Intervention programme on medication compliance and quality of life among elderly with chronic illness
- Conditions
- Health Condition 1: I152- Hypertension secondary to endocrine disorders
- Registration Number
- CTRI/2018/10/015962
- Lead Sponsor
- Jeyalakshmi K
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
The rural area in villages which are covered by ASHA workers has more than 13 elderly with co-morbid conditions of hypertension and diabetes mellitus as on the survey data report.
Elderly in the age group of above 60 years in both gender who resides in selected rural areas of Udupi Taluk.
Elderly who is on prescribed medications for selected chronic illness.
Elderly and family care giver who can speak and understand English or Kannada.
Elderly with chronic illness or their care provider possess the mobile phone.
Elderly with chronic illness those who are willing to participate in this study.
Elderly with chronic illness and of either gender aged above 60 years receiving long term medications for more than 3 months.
Elderly those who could not follow the instructions of the investigator.
Elderly those who are not diagnosed to have any chronic illness and not having medications.
Elderly with chronic illness those who are newly diagnosed and taking medication less than 3 months for their conditions.
Elderly with chronic illness those who had a previous experience of being part of any other project related to drug compliance.
Elderly with any other major diagnosed co-morbid illness such as renal failure and other kidney disease, and other illness such as cancer in any situ, BPH, TB, HIV/AIDS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome measures for Phase I: <br/ ><br>Medication non-compliance of elderly with co-morbid chronic illnesses of hypertension and diabetes mellitus. <br/ ><br>Outcome measures for Phase II: <br/ ><br>Primary Outcome Measures: <br/ ><br>Improvement in medication compliance (Hill Bone Medication Adhrernce scores) scores after 3, 6 and 12 months after applying MBIP. <br/ ><br> <br/ ><br>Timepoint: Baseline, 3, 6, 12 Months
- Secondary Outcome Measures
Name Time Method Improvement on bio-physiological values (Blood sugar, HbA1, BP, Lipid Profile). <br/ ><br>Increase in self-efficacy scores which will be measured by using MASES-R scale <br/ ><br>Increase in quality of life scores which will be measured by using WHO-QOL BREF Scale <br/ ><br>Client satisfaction and acceptability of the Multi-component Behavioral Intervention Programme (MBIP) by using rating scale. <br/ ><br>Timepoint: Baseline, 3, 6, 12 Months